Haworth, K. B., Arnold, M. A., Pierson, C. R., Finlay, J. L., & Cripe, T. P. (2016). TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION. Neuro Oncol.
Stile di citazione ChicagoHaworth, Kellie B., Michael A. Arnold, Christopher R. Pierson, Jonathan L. Finlay, e Timothy P. Cripe. "TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION." Neuro Oncol 2016.
Citazione MLAHaworth, Kellie B., et al. "TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION." Neuro Oncol 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.